跳至主要内容
临床试验/ISRCTN28828586
ISRCTN28828586已完成不适用

AcetylCysteine in the treatment of Sickle Cell Disease

CURAMA Study Group (The Netherlands)0 个研究点目标入组 10 人开始时间: 2007年8月23日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. High performance liquid chromatography confirmed diagnosis of sickle cell anaemia (HbSS), sickle-haemoglobin C disease (HbSC) or sickle cell trait disease (HbSa) genotype
  • 2. Aged 18 to 65 years
  • 3. Written informed consent

排除标准

  • 1. Blood transfusion in the preceding four months
  • 2. Pregnancy or the desire to get pregnant in the following seven months
  • 3. Concomitant use of hydroxyurea, vitamin K antagonists or other oral anticoagulants, or contraindications for NAC
  • 4. Impaired renal function of more than 60% (as assessed by the Kockroft-Gauld equation)
  • 5. Known gastric or duodenal ulcer
  • 6. Concomitant use of anti-hypertensives, sildefanil or nitrates

研究者

发起方
CURAMA Study Group (The Netherlands)

相似试验

AcetylCysteine in the treatment of Sickle Cell... | 临床试验